Based on its innovative MedTech platform for personalized patient support, Nia Health develops medical software. Nia Health’s end-to-end solutions are indication-specific and tailored to the individual needs of each patient.
Nia Health covers a wide variety of use cases in the dermatology and allergology space. Nia Health’s Digital Therapeutics (DTx) combine strong clinical validation with empowerment, gamification and machine learning.
It is Nia Health’s mission to provide a highly engaging and personalized patient experience that removes barriers to health behavior change.
Nia Health’s expertise includes the development, market launch and continuous operation of scalable Digital Health Applications (DiGA). We meet the highest standards in quality management, data security and data protection. With regard to reimbursement options for DTx solutions, we have many years of experience and cooperate with a wide range of health insurance companies. Our solutions have already won numerous innovation awards.
Remote patient monitoring (RPM) opens up new opportunities for clinicians to assess patients’ conditions without having to be physically present in the same room. RPM means access to real-time medical information at a fingertip. Combined with Nia Health’s patient-centric solutions, this allows healthcare professionals to assess a patient’s condition from anywhere via PC or mobile devices. Thus, modifications within the treatment plan can be made in real time.
The requirements for combining, integrating and analysing complex data are growing: environmental factors, personal life circumstances as well as subjective concerns of the patient play an important role. Digital Trial Companions by Nia Health support clinical trials thanks to digital state-of-the-art data collection. The compliance of the study participants is increased through motivating interaction of our state-of-the-art clinical trial tools.
Insights from medical data generated in the “real world” (real-world evidence) – give us unprecedented insights into the correlations around the incidence of diseases and symptoms.
The Eczema App
The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.
The Psoriasis App
Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.
The Eczema App
The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.
The Psoriasis App
Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.
The Acne App
With the acne app milderma, Nia Health launches its third patient-centric DTx solution. Together with patients and key opinion leaders, a digital companion was developed to support patients with chronic acne. milderma is the first acne app that has been approved as a medical device.
SOON AVAILABLE ON
The Eczema App
The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.
The Psoriasis App
Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.
The Acne App
With the acne app milderma, Nia Health launches its third patient-centric DTx solution. Together with patients and key opinion leaders, a digital companion was developed to support patients with chronic acne. milderma is the first acne app that has been approved as a medical device.
We collaborate with best in class dermatologists.
In Nia Health's technology and vision, I see a globally powerful tool for dermatologists and patients with chronic skin conditions.
Prof. Dr. med. Peter Schmid-Grendelmeier Head Allergy Unit & Responsible for Education Dept. Of Dermatology, University Hospital of ZurichUsing modern and innovative technology to improve the quality of care for patients has great potential for the future.
Prof. Dr. med. Margitta Worm Head of Allergology and Immunology, Teaching Coordinator of the Clinic for Dermatology, Venereology and Allergology, Charité BerlinOffering a future-oriented tool that meets the requirements of a medical device for our patients is inevitable. I look forward to working with Nia Health in realizing patients' needs and further digitalizing the healthcare industry.
Dr. med. Andreas Pinter Leading senior doctor, Department for Dermatology, Venereology and Allergology University Hospital Frankfurt a. M.The high medical quality of Nia Health’s Apps and especially the great curriculum for sufferers convinced me.
Prof. Dr. med. Regina Treudler Leading Senior Physician, Clinic for Dermatology, Venereology and Allergology, University of LeipzigDigital tools like Nia Health's medical solutions can sustainably improve patient-physician interactions.
Steven R. Feldman, MD, PhD Professor of Dermatalogy, USANia Health is a pioneer in the digital treatment of chronic skin diseases and offers innovative, patient-centered solutions.
Jonathan Silverberg, MD, PhD, MPH Professor of Dermatology, USAMany challenges have to be mastered to successfully bring a digital medical product to market. Nia Health has already successfully completed the entire process several times. Today, we can leverage our already established platform to launch new DTx solutions even faster.
Dr. Jack Thoms
Member of the Deep Tech Award Jury 2022
Nia Health works with key stakeholders across the pharma and healthcare landscape.
Are you interested in an innovative, medical solution based on our proven tech infrastructure? Let’s build something great together!
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Using digital innovation like Nia Health’s propositions to guide patients through their therapy opens new doors to us doctors by creating a tool that both parties can trust and rely on.
PD Dr. med. Athanasios Tsianakas Medical Director, Department of Dermatology Fachklinik Bad Bentheim